As of April 16, 2025, Kodiak Sciences (KOD) has a market cap of $0.12 billion USD. According to our data, Kodiak Sciences is ranked No.7420 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.12 B |
-76.73%
|
Dec 31, 2024 | $0.52 B |
227.30%
|
Dec 29, 2023 | $0.16 B |
-57.54%
|
Dec 30, 2022 | $0.38 B |
-91.55%
|
Dec 31, 2021 | $4.46 B |
-42.29%
|
Dec 31, 2020 | $7.73 B |
104.18%
|
Dec 31, 2019 | $3.79 B |
913.38%
|
Dec 31, 2018 | $0.37 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
![]() USA
|
![]() Novartis
NVS
|
$218.28 B |
1.163 B
|
![]() Switzerland
|
![]() Bausch Health
BHC
|
$1.68 B |
13.412 M
|
![]() Canada
|
![]() Alcon
ALC
|
$45.67 B |
0.453 B
|
![]() Switzerland
|
![]() Adverum Biotechnologies
ADVM
|
$67.19 M |
-0.000 M
|
![]() USA
|
![]() Ocular Therapeutix
OCUL
|
$1.15 B |
-0.044 B
|
![]() USA
|
![]() Clearside Biomedical
CLSD
|
$63.40 M |
0.000 M
|
![]() USA
|
![]() EyePoint Pharmaceuticals
EYPT
|
$0.39 B |
-0.000 M
|
![]() USA
|
![]() Outlook Therapeutics
OTLK
|
$45.34 M |
-0.000 M
|
![]() USA
|
![]() Ginkgo Bioworks
DNA
|
$0.48 B |
0.101 B
|
![]() USA
|
![]() Kala Pharmaceuticals
KALA
|
$22.78 M |
0.000 M
|
![]() USA
|
Market Cap | = | KOD Stock Price | * | KOD Shares Outstanding |
= | $2.31 | * | 52.75 M | |
= | $0.12 B |